nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000465	0.000536	CcSEcCtD
Acamprosate—Convulsion—Betamethasone—rheumatoid arthritis	0.000464	0.000535	CcSEcCtD
Acamprosate—Convulsion—Dexamethasone—rheumatoid arthritis	0.000464	0.000535	CcSEcCtD
Acamprosate—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000463	0.000534	CcSEcCtD
Acamprosate—Hypertension—Dexamethasone—rheumatoid arthritis	0.000463	0.000533	CcSEcCtD
Acamprosate—Hypertension—Betamethasone—rheumatoid arthritis	0.000463	0.000533	CcSEcCtD
Acamprosate—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.00046	0.00053	CcSEcCtD
Acamprosate—Urticaria—Cyclosporine—rheumatoid arthritis	0.000457	0.000527	CcSEcCtD
Acamprosate—Myalgia—Dexamethasone—rheumatoid arthritis	0.000456	0.000526	CcSEcCtD
Acamprosate—Myalgia—Betamethasone—rheumatoid arthritis	0.000456	0.000526	CcSEcCtD
Acamprosate—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000455	0.000525	CcSEcCtD
Acamprosate—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000455	0.000525	CcSEcCtD
Acamprosate—Anxiety—Dexamethasone—rheumatoid arthritis	0.000455	0.000524	CcSEcCtD
Acamprosate—Anxiety—Betamethasone—rheumatoid arthritis	0.000455	0.000524	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—rheumatoid arthritis	0.000451	0.000519	CcSEcCtD
Acamprosate—Discomfort—Dexamethasone—rheumatoid arthritis	0.000451	0.000519	CcSEcCtD
Acamprosate—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.00045	0.000519	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—rheumatoid arthritis	0.00045	0.000519	CcSEcCtD
Acamprosate—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000449	0.000518	CcSEcCtD
Acamprosate—Pain—Prednisolone—rheumatoid arthritis	0.000448	0.000516	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000448	0.000516	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—rheumatoid arthritis	0.000448	0.000516	CcSEcCtD
Acamprosate—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000445	0.000513	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000445	0.000512	CcSEcCtD
Acamprosate—Nausea—Leflunomide—rheumatoid arthritis	0.000443	0.000511	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000442	0.000509	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000439	0.000506	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000438	0.000505	CcSEcCtD
Acamprosate—Pain—Hydrocortisone—rheumatoid arthritis	0.000438	0.000504	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000437	0.0033	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000437	0.000504	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000437	0.000504	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—rheumatoid arthritis	0.000436	0.000502	CcSEcCtD
Acamprosate—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000435	0.000501	CcSEcCtD
Acamprosate—Infection—Dexamethasone—rheumatoid arthritis	0.000434	0.000501	CcSEcCtD
Acamprosate—Infection—Betamethasone—rheumatoid arthritis	0.000434	0.000501	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000433	0.000499	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000433	0.000499	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000432	0.00326	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000432	0.000498	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000432	0.000498	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—rheumatoid arthritis	0.000432	0.000498	CcSEcCtD
Acamprosate—Anaemia—Prednisone—rheumatoid arthritis	0.000431	0.000497	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HSPD1—rheumatoid arthritis	0.000431	0.00325	CbGpPWpGaD
Acamprosate—Shock—Dexamethasone—rheumatoid arthritis	0.00043	0.000496	CcSEcCtD
Acamprosate—Shock—Betamethasone—rheumatoid arthritis	0.00043	0.000496	CcSEcCtD
Acamprosate—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.00043	0.000495	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	0.00043	0.00324	CbGpPWpGaD
Acamprosate—Agitation—Prednisone—rheumatoid arthritis	0.000429	0.000494	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000428	0.000493	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000428	0.000493	CcSEcCtD
Acamprosate—Tachycardia—Betamethasone—rheumatoid arthritis	0.000427	0.000492	CcSEcCtD
Acamprosate—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000427	0.000492	CcSEcCtD
Acamprosate—Angioedema—Prednisone—rheumatoid arthritis	0.000426	0.000491	CcSEcCtD
Acamprosate—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000424	0.000489	CcSEcCtD
Acamprosate—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000424	0.000489	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000423	0.000488	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000423	0.000487	CcSEcCtD
Acamprosate—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000423	0.000487	CcSEcCtD
Acamprosate—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000422	0.000486	CcSEcCtD
Acamprosate—Malaise—Prednisone—rheumatoid arthritis	0.000421	0.000485	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000419	0.00317	CbGpPWpGaD
Acamprosate—Vertigo—Prednisone—rheumatoid arthritis	0.000419	0.000483	CcSEcCtD
Acamprosate—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000418	0.000482	CcSEcCtD
Acamprosate—Syncope—Prednisone—rheumatoid arthritis	0.000418	0.000482	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—rheumatoid arthritis	0.000418	0.000481	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—NCF1—rheumatoid arthritis	0.000418	0.00315	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C5—rheumatoid arthritis	0.000417	0.00315	CbGpPWpGaD
Acamprosate—Anorexia—Betamethasone—rheumatoid arthritis	0.000417	0.00048	CcSEcCtD
Acamprosate—Anorexia—Dexamethasone—rheumatoid arthritis	0.000417	0.00048	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—rheumatoid arthritis	0.000416	0.00048	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—rheumatoid arthritis	0.000414	0.00313	CbGpPWpGaD
Acamprosate—Asthenia—Cyclosporine—rheumatoid arthritis	0.000413	0.000476	CcSEcCtD
Acamprosate—Pain—Triamcinolone—rheumatoid arthritis	0.000412	0.000475	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—LEP—rheumatoid arthritis	0.000411	0.0031	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000411	0.0031	CbGpPWpGaD
Acamprosate—Loss of consciousness—Prednisone—rheumatoid arthritis	0.00041	0.000473	CcSEcCtD
Acamprosate—Hypotension—Dexamethasone—rheumatoid arthritis	0.000409	0.000471	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—rheumatoid arthritis	0.000409	0.000471	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000408	0.00308	CbGpPWpGaD
Acamprosate—Pruritus—Cyclosporine—rheumatoid arthritis	0.000407	0.00047	CcSEcCtD
Acamprosate—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000407	0.000469	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000405	0.000466	CcSEcCtD
Acamprosate—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000405	0.000466	CcSEcCtD
Acamprosate—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000405	0.000466	CcSEcCtD
Acamprosate—Convulsion—Prednisone—rheumatoid arthritis	0.000404	0.000466	CcSEcCtD
Acamprosate—Hypertension—Prednisone—rheumatoid arthritis	0.000403	0.000464	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TLR4—rheumatoid arthritis	0.000403	0.00304	CbGpPWpGaD
Acamprosate—Chills—Methotrexate—rheumatoid arthritis	0.000402	0.000463	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1A—rheumatoid arthritis	0.000402	0.00303	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL10—rheumatoid arthritis	0.000399	0.00302	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000398	0.000459	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000398	0.000459	CcSEcCtD
Acamprosate—Myalgia—Prednisone—rheumatoid arthritis	0.000397	0.000458	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—rheumatoid arthritis	0.000397	0.000458	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000397	0.000458	CcSEcCtD
Acamprosate—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000396	0.000457	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—SPP1—rheumatoid arthritis	0.000396	0.00299	CbGpPWpGaD
Acamprosate—Anxiety—Prednisone—rheumatoid arthritis	0.000396	0.000456	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—rheumatoid arthritis	0.000396	0.000456	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—rheumatoid arthritis	0.000395	0.000456	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—rheumatoid arthritis	0.000395	0.000456	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000394	0.000455	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP2—rheumatoid arthritis	0.000394	0.00298	CbGpPWpGaD
Acamprosate—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000394	0.000454	CcSEcCtD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—rheumatoid arthritis	0.000393	0.00297	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000393	0.000453	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000393	0.000453	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000393	0.000453	CcSEcCtD
Acamprosate—Discomfort—Prednisone—rheumatoid arthritis	0.000392	0.000452	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—rheumatoid arthritis	0.000392	0.000452	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000392	0.00296	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000392	0.00296	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RBPJ—rheumatoid arthritis	0.000392	0.00296	CbGpPWpGaD
Acamprosate—Malnutrition—Methotrexate—rheumatoid arthritis	0.00039	0.000449	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000386	0.000445	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—SPP1—rheumatoid arthritis	0.000386	0.00291	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—ICAM1—rheumatoid arthritis	0.000386	0.00291	CbGpPWpGaD
Acamprosate—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000385	0.000444	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000385	0.000444	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP2—rheumatoid arthritis	0.000384	0.0029	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—NOS2—rheumatoid arthritis	0.000383	0.00289	CbGpPWpGaD
Acamprosate—Urticaria—Triamcinolone—rheumatoid arthritis	0.000383	0.000441	CcSEcCtD
Acamprosate—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000382	0.00044	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000382	0.00044	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—RBPJ—rheumatoid arthritis	0.000382	0.00288	CbGpPWpGaD
Acamprosate—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000381	0.000439	CcSEcCtD
Acamprosate—Dizziness—Cyclosporine—rheumatoid arthritis	0.000381	0.000439	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000381	0.000439	CcSEcCtD
Acamprosate—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.00038	0.000438	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.00038	0.000438	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—rheumatoid arthritis	0.00038	0.000438	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—C5—rheumatoid arthritis	0.000379	0.00286	CbGpPWpGaD
Acamprosate—Infection—Prednisone—rheumatoid arthritis	0.000378	0.000436	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000377	0.000435	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000377	0.000435	CcSEcCtD
Acamprosate—Back pain—Methotrexate—rheumatoid arthritis	0.000377	0.000435	CcSEcCtD
Acamprosate—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000377	0.000435	CcSEcCtD
Acamprosate—Shock—Prednisone—rheumatoid arthritis	0.000375	0.000432	CcSEcCtD
Acamprosate—Pain—Betamethasone—rheumatoid arthritis	0.000374	0.000431	CcSEcCtD
Acamprosate—Pain—Dexamethasone—rheumatoid arthritis	0.000374	0.000431	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—MED1—rheumatoid arthritis	0.000372	0.00281	CbGpPWpGaD
Acamprosate—Tachycardia—Prednisone—rheumatoid arthritis	0.000372	0.000428	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCR5—rheumatoid arthritis	0.00037	0.00279	CbGpPWpGaD
Acamprosate—Skin disorder—Prednisone—rheumatoid arthritis	0.00037	0.000426	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NR3C1—rheumatoid arthritis	0.00037	0.00279	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	0.000369	0.00279	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000368	0.000424	CcSEcCtD
Acamprosate—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000367	0.000423	CcSEcCtD
Acamprosate—Vomiting—Cyclosporine—rheumatoid arthritis	0.000366	0.000422	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—rheumatoid arthritis	0.000366	0.00276	CbGpPWpGaD
Acamprosate—Rash—Cyclosporine—rheumatoid arthritis	0.000363	0.000418	CcSEcCtD
Acamprosate—Anorexia—Prednisone—rheumatoid arthritis	0.000363	0.000418	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—MED1—rheumatoid arthritis	0.000363	0.00274	CbGpPWpGaD
Acamprosate—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000363	0.000418	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	0.000362	0.00274	CbGpPWpGaD
Acamprosate—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000362	0.000417	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000362	0.000417	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—C3—rheumatoid arthritis	0.000362	0.00273	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—rheumatoid arthritis	0.000361	0.00273	CbGpPWpGaD
Acamprosate—Headache—Cyclosporine—rheumatoid arthritis	0.000361	0.000416	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—rheumatoid arthritis	0.00036	0.000415	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.00036	0.000415	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.00036	0.000415	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000359	0.00271	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000358	0.000412	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000358	0.000412	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000356	0.00269	CbGpPWpGaD
Acamprosate—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000355	0.000409	CcSEcCtD
Acamprosate—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000354	0.000408	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—rheumatoid arthritis	0.000352	0.00266	CbGpPWpGaD
Acamprosate—Malaise—Methotrexate—rheumatoid arthritis	0.000352	0.000405	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000351	0.00265	CbGpPWpGaD
Acamprosate—Vertigo—Methotrexate—rheumatoid arthritis	0.00035	0.000404	CcSEcCtD
Acamprosate—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.00035	0.000404	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—rheumatoid arthritis	0.000349	0.000402	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000347	0.00262	CbGpPWpGaD
Acamprosate—Urticaria—Dexamethasone—rheumatoid arthritis	0.000347	0.0004	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—rheumatoid arthritis	0.000347	0.0004	CcSEcCtD
Acamprosate—GRIN2C—Alzheimers Disease—TP53—rheumatoid arthritis	0.000347	0.00262	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000347	0.0004	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—rheumatoid arthritis	0.000347	0.000399	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—rheumatoid arthritis	0.000346	0.000398	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000346	0.000398	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000346	0.000398	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000346	0.000398	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000346	0.000398	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CCL2—rheumatoid arthritis	0.000345	0.00261	CbGpPWpGaD
Acamprosate—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000345	0.000398	CcSEcCtD
Acamprosate—Insomnia—Prednisone—rheumatoid arthritis	0.000344	0.000397	CcSEcCtD
Acamprosate—Nausea—Cyclosporine—rheumatoid arthritis	0.000342	0.000394	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—rheumatoid arthritis	0.000342	0.000394	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—rheumatoid arthritis	0.000341	0.000393	CcSEcCtD
Acamprosate—Cough—Methotrexate—rheumatoid arthritis	0.00034	0.000392	CcSEcCtD
Acamprosate—Pruritus—Methylprednisolone—rheumatoid arthritis	0.00034	0.000392	CcSEcCtD
Acamprosate—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000338	0.00039	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—rheumatoid arthritis	0.000338	0.000389	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—rheumatoid arthritis	0.000335	0.000386	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—STAT1—rheumatoid arthritis	0.000332	0.00251	CbGpPWpGaD
Acamprosate—Arthralgia—Methotrexate—rheumatoid arthritis	0.000332	0.000383	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—rheumatoid arthritis	0.000332	0.000383	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—rheumatoid arthritis	0.000332	0.000383	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PLB1—rheumatoid arthritis	0.000331	0.0025	CbGpPWpGaD
Acamprosate—Decreased appetite—Prednisone—rheumatoid arthritis	0.000331	0.000382	CcSEcCtD
Acamprosate—Rash—Prednisolone—rheumatoid arthritis	0.00033	0.000381	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—rheumatoid arthritis	0.00033	0.00038	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.00033	0.00038	CcSEcCtD
Acamprosate—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000329	0.000379	CcSEcCtD
Acamprosate—Headache—Prednisolone—rheumatoid arthritis	0.000328	0.000378	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—rheumatoid arthritis	0.000328	0.000378	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—GATA3—rheumatoid arthritis	0.000326	0.00246	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000326	0.00246	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000326	0.00246	CbGpPWpGaD
Acamprosate—Constipation—Prednisone—rheumatoid arthritis	0.000326	0.000375	CcSEcCtD
Acamprosate—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000325	0.000375	CcSEcCtD
Acamprosate—Rash—Hydrocortisone—rheumatoid arthritis	0.000323	0.000372	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—rheumatoid arthritis	0.000323	0.00244	CbGpPWpGaD
Acamprosate—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000322	0.000372	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—rheumatoid arthritis	0.000321	0.00037	CcSEcCtD
Acamprosate—Headache—Hydrocortisone—rheumatoid arthritis	0.000321	0.00037	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000319	0.00241	CbGpPWpGaD
Acamprosate—Dizziness—Triamcinolone—rheumatoid arthritis	0.000319	0.000367	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000318	0.000367	CcSEcCtD
Acamprosate—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000318	0.000366	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	0.000317	0.00239	CbGpPWpGaD
Acamprosate—Infection—Methotrexate—rheumatoid arthritis	0.000316	0.000364	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1RN—rheumatoid arthritis	0.000316	0.00239	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000314	0.000362	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—rheumatoid arthritis	0.000314	0.000362	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—rheumatoid arthritis	0.000314	0.000362	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PTPRC—rheumatoid arthritis	0.000312	0.00236	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000312	0.000359	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000311	0.000359	CcSEcCtD
Acamprosate—Nausea—Prednisolone—rheumatoid arthritis	0.000311	0.000359	CcSEcCtD
Acamprosate—Pruritus—Dexamethasone—rheumatoid arthritis	0.000309	0.000357	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—rheumatoid arthritis	0.000309	0.000357	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—rheumatoid arthritis	0.000309	0.000356	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000308	0.000355	CcSEcCtD
Acamprosate—Vomiting—Triamcinolone—rheumatoid arthritis	0.000306	0.000353	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000306	0.00231	CbGpPWpGaD
Acamprosate—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000306	0.000352	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000305	0.0023	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000305	0.0023	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PTPRC—rheumatoid arthritis	0.000305	0.0023	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	0.000304	0.0023	CbGpPWpGaD
Acamprosate—Nausea—Hydrocortisone—rheumatoid arthritis	0.000304	0.00035	CcSEcCtD
Acamprosate—Rash—Triamcinolone—rheumatoid arthritis	0.000304	0.00035	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000304	0.00035	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—rheumatoid arthritis	0.000303	0.00035	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—rheumatoid arthritis	0.000303	0.000349	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000303	0.000349	CcSEcCtD
Acamprosate—Urticaria—Prednisone—rheumatoid arthritis	0.000302	0.000349	CcSEcCtD
Acamprosate—Headache—Triamcinolone—rheumatoid arthritis	0.000302	0.000348	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000302	0.00228	CbGpPWpGaD
Acamprosate—Headache—Methylprednisolone—rheumatoid arthritis	0.000301	0.000347	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—rheumatoid arthritis	0.000301	0.000347	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—rheumatoid arthritis	0.000301	0.000347	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—rheumatoid arthritis	0.0003	0.00227	CbGpPWpGaD
Acamprosate—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000299	0.000345	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000299	0.000345	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—rheumatoid arthritis	0.000297	0.000343	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—rheumatoid arthritis	0.000296	0.00224	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—rheumatoid arthritis	0.000294	0.00222	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.00029	0.000334	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—POMC—rheumatoid arthritis	0.000289	0.00218	CbGpPWpGaD
Acamprosate—Dizziness—Dexamethasone—rheumatoid arthritis	0.000289	0.000333	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—rheumatoid arthritis	0.000289	0.000333	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—rheumatoid arthritis	0.000289	0.00218	CbGpPWpGaD
Acamprosate—Insomnia—Methotrexate—rheumatoid arthritis	0.000288	0.000332	CcSEcCtD
Acamprosate—Nausea—Triamcinolone—rheumatoid arthritis	0.000286	0.00033	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000286	0.000329	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—rheumatoid arthritis	0.000286	0.000329	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000285	0.00215	CbGpPWpGaD
Acamprosate—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000284	0.000327	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000283	0.00214	CbGpPWpGaD
Acamprosate—Somnolence—Methotrexate—rheumatoid arthritis	0.000283	0.000326	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—rheumatoid arthritis	0.000282	0.00213	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000281	0.000323	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—rheumatoid arthritis	0.00028	0.000323	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000278	0.0021	CbGpPWpGaD
Acamprosate—Vomiting—Betamethasone—rheumatoid arthritis	0.000278	0.00032	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—rheumatoid arthritis	0.000278	0.00032	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000277	0.00209	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000277	0.00209	CbGpPWpGaD
Acamprosate—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000277	0.000319	CcSEcCtD
Acamprosate—Rash—Dexamethasone—rheumatoid arthritis	0.000276	0.000318	CcSEcCtD
Acamprosate—Rash—Betamethasone—rheumatoid arthritis	0.000276	0.000318	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6R—rheumatoid arthritis	0.000275	0.00208	CbGpPWpGaD
Acamprosate—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000275	0.000317	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—rheumatoid arthritis	0.000275	0.000317	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000275	0.000317	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000274	0.00207	CbGpPWpGaD
Acamprosate—Headache—Betamethasone—rheumatoid arthritis	0.000274	0.000316	CcSEcCtD
Acamprosate—Headache—Dexamethasone—rheumatoid arthritis	0.000274	0.000316	CcSEcCtD
Acamprosate—Asthenia—Prednisone—rheumatoid arthritis	0.000273	0.000315	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—rheumatoid arthritis	0.000273	0.00206	CbGpPWpGaD
Acamprosate—Pain—Methotrexate—rheumatoid arthritis	0.000272	0.000314	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CXCL13—rheumatoid arthritis	0.00027	0.00204	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.00027	0.00204	CbGpPWpGaD
Acamprosate—Pruritus—Prednisone—rheumatoid arthritis	0.000269	0.000311	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PRKCQ—rheumatoid arthritis	0.000268	0.00202	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—rheumatoid arthritis	0.000266	0.00201	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—rheumatoid arthritis	0.000265	0.002	CbGpPWpGaD
Acamprosate—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000262	0.000302	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TNF—rheumatoid arthritis	0.000262	0.00198	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—rheumatoid arthritis	0.000262	0.00198	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PRKCQ—rheumatoid arthritis	0.000261	0.00197	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SPP1—rheumatoid arthritis	0.000261	0.00197	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—rheumatoid arthritis	0.000261	0.00197	CbGpPWpGaD
Acamprosate—Diarrhoea—Prednisone—rheumatoid arthritis	0.000261	0.0003	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.00026	0.0003	CcSEcCtD
Acamprosate—Nausea—Betamethasone—rheumatoid arthritis	0.00026	0.000299	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—rheumatoid arthritis	0.00026	0.000299	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—rheumatoid arthritis	0.000259	0.00196	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000258	0.00195	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	0.000256	0.00193	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—rheumatoid arthritis	0.000255	0.00193	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000253	0.00191	CbGpPWpGaD
Acamprosate—Urticaria—Methotrexate—rheumatoid arthritis	0.000253	0.000291	CcSEcCtD
Acamprosate—Dizziness—Prednisone—rheumatoid arthritis	0.000252	0.00029	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000252	0.00029	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000252	0.00029	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	0.000251	0.0019	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—rheumatoid arthritis	0.000247	0.00187	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000245	0.00185	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000243	0.00184	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TLE3—rheumatoid arthritis	0.000243	0.00184	CbGpPWpGaD
Acamprosate—Vomiting—Prednisone—rheumatoid arthritis	0.000242	0.000279	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000241	0.00182	CbGpPWpGaD
Acamprosate—Rash—Prednisone—rheumatoid arthritis	0.00024	0.000277	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—rheumatoid arthritis	0.00024	0.000276	CcSEcCtD
Acamprosate—Headache—Prednisone—rheumatoid arthritis	0.000239	0.000275	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000234	0.00027	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000232	0.00175	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000232	0.00175	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—rheumatoid arthritis	0.000231	0.00174	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000229	0.00173	CbGpPWpGaD
Acamprosate—Asthenia—Methotrexate—rheumatoid arthritis	0.000228	0.000263	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PTK2—rheumatoid arthritis	0.000228	0.00172	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1A—rheumatoid arthritis	0.000228	0.00172	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—rheumatoid arthritis	0.000226	0.00171	CbGpPWpGaD
Acamprosate—Nausea—Prednisone—rheumatoid arthritis	0.000226	0.000261	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—rheumatoid arthritis	0.000225	0.0017	CbGpPWpGaD
Acamprosate—Pruritus—Methotrexate—rheumatoid arthritis	0.000225	0.00026	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—C5—rheumatoid arthritis	0.000224	0.00169	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000224	0.00169	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000223	0.00169	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PTPRC—rheumatoid arthritis	0.000223	0.00168	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.000223	0.00168	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PTK2—rheumatoid arthritis	0.000222	0.00168	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFATC1—rheumatoid arthritis	0.00022	0.00166	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	0.00022	0.00166	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	0.000218	0.00165	CbGpPWpGaD
Acamprosate—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000218	0.000251	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PTPRC—rheumatoid arthritis	0.000217	0.00164	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000211	0.00159	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR6—rheumatoid arthritis	0.00021	0.00159	CbGpPWpGaD
Acamprosate—Dizziness—Methotrexate—rheumatoid arthritis	0.00021	0.000243	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—ADIPOQ—rheumatoid arthritis	0.00021	0.00159	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	0.00021	0.00158	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NR3C1—rheumatoid arthritis	0.000209	0.00158	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000209	0.00158	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	0.000208	0.00157	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NFKB1—rheumatoid arthritis	0.000208	0.00157	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000208	0.00157	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000206	0.00156	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADIPOQ—rheumatoid arthritis	0.000205	0.00155	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK8—rheumatoid arthritis	0.000205	0.00155	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	0.000205	0.00155	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCF2—rheumatoid arthritis	0.000205	0.00155	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C3—rheumatoid arthritis	0.000204	0.00154	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—rheumatoid arthritis	0.000204	0.00154	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NFKB1—rheumatoid arthritis	0.000203	0.00153	CbGpPWpGaD
Acamprosate—Vomiting—Methotrexate—rheumatoid arthritis	0.000202	0.000233	CcSEcCtD
Acamprosate—Rash—Methotrexate—rheumatoid arthritis	0.000201	0.000231	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—rheumatoid arthritis	0.0002	0.000231	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—rheumatoid arthritis	0.0002	0.00151	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000199	0.00151	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000199	0.00151	CbGpPWpGaD
Acamprosate—Headache—Methotrexate—rheumatoid arthritis	0.000199	0.00023	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GZMB—rheumatoid arthritis	0.000198	0.0015	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	0.000195	0.00148	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000192	0.00145	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL3—rheumatoid arthritis	0.000192	0.00145	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PRKCQ—rheumatoid arthritis	0.000191	0.00144	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—rheumatoid arthritis	0.00019	0.00144	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—rheumatoid arthritis	0.00019	0.00143	CbGpPWpGaD
Acamprosate—Nausea—Methotrexate—rheumatoid arthritis	0.000189	0.000218	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SAA1—rheumatoid arthritis	0.000188	0.00142	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000187	0.00141	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PRKCQ—rheumatoid arthritis	0.000186	0.00141	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—C3—rheumatoid arthritis	0.000186	0.0014	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCF1—rheumatoid arthritis	0.000184	0.00139	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	0.000179	0.00135	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	0.000177	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD28—rheumatoid arthritis	0.000177	0.00134	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6ST—rheumatoid arthritis	0.000172	0.0013	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6ST—rheumatoid arthritis	0.000168	0.00127	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—rheumatoid arthritis	0.000168	0.00127	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000167	0.00126	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000164	0.00124	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000164	0.00124	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000163	0.00123	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PTK2—rheumatoid arthritis	0.000163	0.00123	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000162	0.00123	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000162	0.00122	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	0.000159	0.0012	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PTK2—rheumatoid arthritis	0.000159	0.0012	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	0.000156	0.00118	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6R—rheumatoid arthritis	0.000156	0.00118	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	0.000155	0.00117	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6R—rheumatoid arthritis	0.000153	0.00116	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—rheumatoid arthritis	0.000153	0.00116	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000153	0.00115	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SYK—rheumatoid arthritis	0.000152	0.00115	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	0.000152	0.00115	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6R—rheumatoid arthritis	0.00015	0.00113	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000149	0.00113	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—POMC—rheumatoid arthritis	0.000148	0.00112	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT1—rheumatoid arthritis	0.000147	0.00111	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—rheumatoid arthritis	0.000146	0.00111	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000145	0.0011	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000145	0.00109	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000145	0.00109	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—rheumatoid arthritis	0.000143	0.00108	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—TYK2—rheumatoid arthritis	0.00014	0.00106	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NFKB1—rheumatoid arthritis	0.000137	0.00104	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	0.000137	0.00103	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—TYK2—rheumatoid arthritis	0.000136	0.00103	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—rheumatoid arthritis	0.000135	0.00102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP3—rheumatoid arthritis	0.000132	0.000996	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000132	0.000996	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—rheumatoid arthritis	0.000131	0.000987	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—rheumatoid arthritis	0.000127	0.000962	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTK2—rheumatoid arthritis	0.000127	0.000959	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000126	0.000955	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL5—rheumatoid arthritis	0.000125	0.00094	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	0.000124	0.000934	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6ST—rheumatoid arthritis	0.000123	0.000927	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	0.000123	0.000927	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2—rheumatoid arthritis	0.000123	0.000926	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000121	0.000912	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6ST—rheumatoid arthritis	0.00012	0.000904	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	0.000119	0.000896	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SPP1—rheumatoid arthritis	0.000115	0.000871	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000115	0.000867	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—rheumatoid arthritis	0.000112	0.000847	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	0.000111	0.000836	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000111	0.000835	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—rheumatoid arthritis	0.00011	0.000831	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—rheumatoid arthritis	0.00011	0.000829	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—rheumatoid arthritis	0.00011	0.000828	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6R—rheumatoid arthritis	0.00011	0.000827	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—rheumatoid arthritis	0.000107	0.00081	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6R—rheumatoid arthritis	0.000107	0.000806	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—rheumatoid arthritis	0.000105	0.000789	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—rheumatoid arthritis	0.000102	0.000771	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—rheumatoid arthritis	0.000102	0.000769	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	0.0001	0.000759	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TYK2—rheumatoid arthritis	9.98e-05	0.000753	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—rheumatoid arthritis	9.89e-05	0.000747	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TYK2—rheumatoid arthritis	9.72e-05	0.000734	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—rheumatoid arthritis	9.64e-05	0.000728	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FN1—rheumatoid arthritis	9.62e-05	0.000727	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6ST—rheumatoid arthritis	9.58e-05	0.000724	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD80—rheumatoid arthritis	9.23e-05	0.000697	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—rheumatoid arthritis	8.77e-05	0.000662	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	8.61e-05	0.00065	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—rheumatoid arthritis	8.58e-05	0.000648	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6R—rheumatoid arthritis	8.55e-05	0.000646	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—rheumatoid arthritis	7.86e-05	0.000593	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TYK2—rheumatoid arthritis	7.79e-05	0.000588	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NFKB1—rheumatoid arthritis	7.77e-05	0.000587	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—rheumatoid arthritis	7.66e-05	0.000578	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—rheumatoid arthritis	7.65e-05	0.000577	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NFKB1—rheumatoid arthritis	7.58e-05	0.000572	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—rheumatoid arthritis	7.05e-05	0.000533	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	6.95e-05	0.000525	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—rheumatoid arthritis	6.88e-05	0.000519	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—rheumatoid arthritis	6.84e-05	0.000516	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—rheumatoid arthritis	6.78e-05	0.000512	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—rheumatoid arthritis	6.67e-05	0.000503	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—rheumatoid arthritis	6.48e-05	0.000489	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—rheumatoid arthritis	6.47e-05	0.000489	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—rheumatoid arthritis	6.45e-05	0.000487	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—rheumatoid arthritis	6.31e-05	0.000477	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—rheumatoid arthritis	6.13e-05	0.000463	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	6.07e-05	0.000458	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—rheumatoid arthritis	6.05e-05	0.000457	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	5.97e-05	0.00045	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—rheumatoid arthritis	5.89e-05	0.000445	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.73e-05	0.000433	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.63e-05	0.000425	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	5.51e-05	0.000416	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	5.06e-05	0.000382	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.92e-05	0.000372	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—rheumatoid arthritis	4.88e-05	0.000368	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—rheumatoid arthritis	4.76e-05	0.000359	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—rheumatoid arthritis	4.16e-05	0.000314	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—rheumatoid arthritis	3.81e-05	0.000288	CbGpPWpGaD
